Abstract
The prevalence of inflammation is high among patients with chronic heart failure (CHF). Reduced ejection fraction was associated with frequency of CD4+ T cells of leukocytes. Therefore, we investigated inflammatory cytokines of expression markers in CD4+ T cells in patients with CHF. Blood samples were obtained from 103 patients with CHF, from 83 patients with stable angina (SA), and from 57 controls. Interferon-γ (IFN-γ)-positive CD4+ T cells and interleukin-4 (IL-4)-positive CD4+ T cells were analyzed using 3-color flow cytometry. The frequency (%) of IFN-γ-positive CD4+ T cells increased in patients with CHF compared with those with SA and controls (CHF: 28.3 ± 13.8, SA: 23.50 ± 10.38, controls: 19.00 ± 7.45, P < 0.001). There was no significant difference in the frequency of IL-4-positive CD4+ T cells among the three groups. The frequencies of CD4+ T cells that stained for IFN-γ decreased from 32.37% ± 16.40% on admission to 26.91% ± 12.53% after 2 weeks in 26 patients with CHF. B-type natriuretic peptide (pg/ml) and high-sensitivity C-reactive protein (mg/dl) levels decreased from 251.7 ± 150.4 and 0.64 ± 0.78 on admission to 208.2 ± 166.4 and 0.36 ± 0.34 after 2 weeks in the 26 patients with CHF. We have demonstrated expression of IFN-γ production of CD4+ T cells during CHF. Prevention of unwanted T cell activation could represent a new target in the treatment of CHF.
Similar content being viewed by others
References
M Jessup S Brozena (2003) ArticleTitleHeart failure N Engl J Med 348 2007–2018 Occurrence Handle12748317 Occurrence Handle10.1056/NEJMra021498
AD Luster (1998) ArticleTitleChemokines – chemotactic cytokines that mediate inflammation N Engl J Med 338 436–445 Occurrence Handle9459648 Occurrence Handle10.1056/NEJM199802123380706 Occurrence Handle1:CAS:528:DyaK1cXht1Wrsrc%3D
C Murdoch A Finn (2000) ArticleTitleChemokine receptors and their role in inflammation and infectious diseases Blood 95 3032–3043 Occurrence Handle10807766 Occurrence Handle1:CAS:528:DC%2BD3cXjt1equrk%3D
K Setsuta Y Seino T Ogawa T Ohtsuka K Seimiya T Takano (2004) ArticleTitleOngoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system Circ J 68 747–750 Occurrence Handle15277733 Occurrence Handle10.1253/circj.68.747 Occurrence Handle1:CAS:528:DC%2BD2cXmvF2ksbk%3D
T Sugamori Y Ishibashi T Shimada N Takahashi T Sakane S Ohata Y Kunizawa S Inoue K Nakamura Y Ohta H Shimizu H Katoh N Oyake Y Murakami M Hashimoto (2002) ArticleTitleIncreased nitric oxide in proportion to the severity of heart failure in patients with dilated cardiomyopathy: close correlation of tumor necrosis factor-alpha with systemic and local production of nitric oxide Circ J 66 627–632 Occurrence Handle12135128 Occurrence Handle10.1253/circj.66.627 Occurrence Handle1:CAS:528:DC%2BD38XlsF2ms7g%3D
P Aukrust T Ueland F Muller AK Andreassen I Nordoy H Aas J Kjekshus S Simonsen SS Froland L Gullestad (1998) ArticleTitleElevated circulating levels of C-C chemokines in patients with congestive heart failure Circulation 97 1136–1143 Occurrence Handle9537339 Occurrence Handle1:STN:280:DyaK1c7ps1Krtw%3D%3D
JK Damas L Gullestad T Ueland NO Solum S Simonsen SS Froland P Aukrust (2000) ArticleTitleCXC-chemokines, a new group of cytokines in congestive heart failure-possible role of platelets and monocytes Cardiovasc Res 45 428–436 Occurrence Handle10728363 Occurrence Handle10.1016/S0008-6363(99)00262-X Occurrence Handle1:CAS:528:DC%2BD3cXotFKnsA%3D%3D
JK Damas HG Eiken E Oie V Bjerkeli A Yndestad T Ueland T Tonnessen OR Geiran H Aass S Simonsen G Christensen SS Froland H Attramadal L Gullestad P Aukrust (2000) ArticleTitleMyocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure Cardiovasc Res 47 778–787 Occurrence Handle10974226 Occurrence Handle10.1016/S0008-6363(00)00142-5 Occurrence Handle1:CAS:528:DC%2BD3cXmt1WqtbY%3D
B Levine J Kalman L Mayer HM Fillit M Packer (1990) ArticleTitleElevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 236–241 Occurrence Handle2195340 Occurrence Handle1:STN:280:DyaK3czgvF2isA%3D%3D Occurrence Handle10.1056/NEJM199007263230405
P Aukrust T Ueland E Lien K Bendtzen F Muller AK Andreassen I Nordoy H Aass T Espevik S Simonsen SS Froland L Gullestad (1999) ArticleTitleCytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 83 376–382 Occurrence Handle10072227 Occurrence Handle10.1016/S0002-9149(98)00872-8 Occurrence Handle1:STN:280:DyaK1M7ntVCnsQ%3D%3D
MK Erol S Erol M Koruk M Ertek E Bozkurt (2004) ArticleTitleEffects of interferon-alpha therapy on cardiac function in patients with chronic hepatitis B infection Heart Vessels 19 263–266 Occurrence Handle15799171 Occurrence Handle10.1007/s00380-004-0780-x
H Hirota M Izumi T Hamaguchi S Sugiyama E Murakami K Kunisada Y Fujio Y Oshima Y Nakaoka K Yamauchi-Takihara (2004) ArticleTitleCirculating interleukin-6 family cytokines and their receptors in patients with congestive heart failure Heart Vessels 19 237–241 Occurrence Handle15372299 Occurrence Handle10.1007/s00380-004-0770-z
S Satoh JI Oyama N Suematsu T Kadokami N Shimoyama M Okutsu T Inoue M Sugano N Makino (2006) ArticleTitleIncreased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure Int J Cardiol 111 405–412 Occurrence Handle16271779 Occurrence Handle10.1016/j.ijcard.2005.08.021
A Yndestad AM Holm F Muller S Simonsen SS Froland L Gullestad P Aukrust (2003) ArticleTitleEnhanced expression of inflammatory cytokines and activation markers in T cells from patients with chronic heart failure Cardiovasc Res 60 141–146 Occurrence Handle14522416 Occurrence Handle10.1016/S0008-6363(03)00362-6 Occurrence Handle1:CAS:528:DC%2BD3sXns12ku7Y%3D
T Tsutamoto A Wada K Maeda N Mabuchi M Hayashi T Tsutsui M Ohnishi M Sawaki M Fujii T Matsumoto M Kinoshita (2000) ArticleTitleAngiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure J Am Coll Cardiol 35 714–721 Occurrence Handle10716475 Occurrence Handle10.1016/S0735-1097(99)00594-X Occurrence Handle1:CAS:528:DC%2BD3cXitVCjsbk%3D
T Hayashi K Sohmiya A Ukimura S Endoh T Mori H Shimomura M Okabe F Terasaki Y Kitaura (2003) ArticleTitleAngiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart Heart 89 1236–1242 Occurrence Handle12975429 Occurrence Handle10.1136/heart.89.10.1236 Occurrence Handle1:CAS:528:DC%2BD3sXosFaltrs%3D
WH Yin JW Chen HL Jen MC Chiang WP Huang AN Feng MS Young SJ Lin (2004) ArticleTitleIndependent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 931–938 Occurrence Handle15131554 Occurrence Handle10.1016/j.ahj.2003.11.021 Occurrence Handle1:CAS:528:DC%2BD2cXjsl2gsLw%3D
C Gabay I Kushner (1999) ArticleTitleAcute-phase proteins and other systemic responses to inflammation N Engl J Med 340 448–454 Occurrence Handle9971870 Occurrence Handle10.1056/NEJM199902113400607 Occurrence Handle1:STN:280:DyaK1M7it1KhtA%3D%3D
DJ Pinsky B Cai X Yang C Rodriguez RR Sciacca PJ Cannon (1995) ArticleTitleThe lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta J Clin Invest 95 677–685 Occurrence Handle7532189 Occurrence Handle1:CAS:528:DyaK2MXjsV2rsrY%3D
B Chatterjee UE Nydegger P Mohacsi (2000) ArticleTitleSerum erythropoietin in heart failure patients treated with ACE-inhibitors or AT1 antagonists Eur J Heart Fail 2 393–398 Occurrence Handle11113716 Occurrence Handle10.1016/S1388-9842(00)00110-0 Occurrence Handle1:CAS:528:DC%2BD3MXktFCgtA%3D%3D
L Dalla Libera B Ravara A Angelini K Rossini M Sandri G Thiene G Battista Ambrosio G Vescovo (2001) ArticleTitleBeneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure Circulation 103 2195–2200 Occurrence Handle11331262 Occurrence Handle1:CAS:528:DC%2BD3MXjvFOntrw%3D
M Fujii A Wada T Tsutamoto M Ohnishi T Isono M Kinoshita (2002) ArticleTitleBradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure Hypertension 39 952–957 Occurrence Handle12019275 Occurrence Handle10.1161/01.HYP.0000015613.78314.9E Occurrence Handle1:CAS:528:DC%2BD38Xkt1agtrs%3D
M Yoshimura H Yasue K Okumura H Ogawa M Jougasaki M Mukoyama K Nakao H Imura (1993) ArticleTitleDifferent secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 464–469 Occurrence Handle8425293 Occurrence Handle1:STN:280:DyaK3s7ksFCmuw%3D%3D
H Yasue K Obata K Okumura M Kurose H Ogawa K Matsuyama M Jougasaki Y Saito K Nakao H Imura (1989) ArticleTitleIncreased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy J Clin Invest 83 46–51 Occurrence Handle2521343 Occurrence Handle1:STN:280:DyaL1M%2FptlCntg%3D%3D Occurrence Handle10.1172/JCI113883
W Johnson T Omland C Hall C Lucas OL Myking C Collins M Pfeffer JL Rouleau LW Stevenson (2002) ArticleTitleNeurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure J Am Coll Cardiol 39 1623–1629 Occurrence Handle12020489 Occurrence Handle10.1016/S0735-1097(02)01814-4 Occurrence Handle1:CAS:528:DC%2BD38XktlGqurw%3D
K Maeda T Tsutamoto A Wada N Mabuchi M Hayashi T Tsutsui M Ohnishi M Sawaki M Fujii T Matsumoto M Kinoshita (2000) ArticleTitleHigh levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 1587–1593 Occurrence Handle11079662 Occurrence Handle10.1016/S0735-1097(00)00912-8 Occurrence Handle1:CAS:528:DC%2BD3cXosFKgsLg%3D
S Bellosta D Via M Canavesi P Pfister R Fumagalli R Paoletti F Bernini (1998) ArticleTitleHMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages Arterioscler Thromb Vasc Biol 18 1671–1678 Occurrence Handle9812903 Occurrence Handle1:CAS:528:DyaK1cXnvFShsbo%3D
M Aikawa E Rabkin S Sugiyama SJ Voglic Y Fukumoto Y Furukawa M Shiomi FJ Schoen P Libby (2001) ArticleTitleAn HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro Circulation 103 276–283 Occurrence Handle11208689 Occurrence Handle1:CAS:528:DC%2BD3MXhtFaitr4%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukunaga, T., Soejima, H., Irie, A. et al. Expression of interferon-g and interleukin-4 production in CD4+ T cells in patients with chronic heart failure. Heart Vessels 22, 178–183 (2007). https://doi.org/10.1007/s00380-006-0955-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-006-0955-8